Parvovirus B-19 infections in pregnant women in day care facilities: Health economic analysis of prohibition to employ seronegative women;Parvovirus-B19-Infektionen bei Schwangeren in der Kinderbetreuung: Gesundheitsökonomische Analyse eines Beschäftigungsverbots

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 50, Issue 11, 2007, Pages 1369-1378

  Gartner B ^a   Enders, M ^b   Luft Duchow, C ^c   Bocharov, G ^d   Modorow, S ^e  

^a SAARLAND UNIVERSITY   (Germany)

^b Labor Prof Enders   (Germany)

^c Russian Academy of Science ^*

^d RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

^e UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Fifth disease; Health economics; Miscarriage; Pregnancy; Stillbirth

Indexed keywords

ADULT; ARTICLE; COST BENEFIT ANALYSIS; DAY CARE; ECONOMICS; EMPLOYMENT; FEMALE; GERMANY; HEALTH CARE COST; HUMAN; IMMUNOLOGY; PARVOVIRUS; PREGNANCY; PREGNANCY COMPLICATION; PREVALENCE; STATISTICS; VIRUS INFECTION;

ADULT; COST-BENEFIT ANALYSIS; DAY CARE; EMPLOYMENT; FEMALE; GERMANY; HEALTH CARE COSTS; HUMANS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE;

EID: 36348957391     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-007-0367-7     Document Type: Article

References (27)

1. Enders M, Weidner A, Zoellner I, et al. (2004) Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 24:513-518
2. Modrow S, Gärtner B (2006) Parvovirus-B19-Infektionen in der Schwangerschaft. Dtsch Ärztebl 103:A-2869-2876
3. Valeur-Jensen AK, Pedersen CB, Westergaard T, et al. (1999) Risk factors for parvovirus B19 infection in pregnancy. JAMA 281:1099-1105
4. Röhrer C, Gärtner BC, Sauerbrei A, et al. (2007) Seroprevalence of parvovirus B19 in the German population. Epidemiol Infect (im Review)
5. Ray SM, Erdman DD, Berschling JD, et al. (1997) Nosocomial exposure to parvovirus B19: low risk of transmission to healthcare workers. Infect Control Hosp Epidemiol 18:109-114
6. Yaegashi N, Niinuma T, Chisaka H, et al. (1998) The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis. J Infect 37:28-35
7. Dowell SF, Torok TJ, Thorp JA, et al. (1995) Parvovirus B19 infection in hospital workers: community or hospital acquisition? J Infect Dis 172:1076-1079
8. Enders G, Miller E (2002) Varicella and herpes zoster in pregnancy and the newborn. In: Arvin A, Gershon A (eds) Varicella-Zoster-Virus: virology and clinical management. Cambridge University Press, Cambridge, pp 317-347
9. Enders M persönliche Mitteilung
10. Statistisches Bundesamt http://www.destatis.de/ 1.8.2005
11. WHO (1999) Reproductive health in refugee situations. http://www.who.int/reproductive-health/publications/interagency_manual_on_RH_in- refugee_situations/a3.pdf
12. Kolvenbach FJ, Haustein T, Krieger S, Weber T (2004) Kindertagesbetreuung in Deutschland 1990-2002, Einrichtungen, Plätze, Personal, Kosten. Statistisches Bundesamt, Wiesbaden
13. Jensen IP, Thorsen P, Jeune B, et al. (2000) An epidemic of parvovirus B19 in a population of 3,596 pregnant women: a study of sociodemographic and medical risk factors. BJOG 107:637-643
14. Alanen A, Kahala K, Vahlberg T, et al. (2005) Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland. BJOG 112:50-56
15. Gilbert NL, Gyorkos TW, Beliveau C, et al. (2005) Seroprevalence of parvovirus B19 infection in daycare educators. Epidemiol Infect 133:299-304
16. Ziyaeyan M, Rasouli M, Alborzi A (2005) The seroprevalence of parvovirus B19 infection among tobe-married girls, pregnant women, and their neonates in Shiraz, Iran. Jpn J Infect Dis 58:95-97
17. Guidozzi F, Ballot D, Rothberg AD (1994) Human B19 parvovirus infection in an obstetric population. A prospective study determining fetal outcome. J Reprod Med 39:36-38
18. Yaegashi N, Niinuma T, Chisaka H, et al. (1999) Serologic study of human parvovirus B19 infection in pregnancy in Japan. J Infect 38:30-35
19. Rodis JF, Quinn DL, Gary GW Jr., et al. (1990) Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study. Am J Obstet Gynecol 163:1168-1171
20. Koch WC, Harger JH, Barnstein B, Adler SP (1998) Serologic and virologic evidence for frequent intrauterine transmission of human parvovirus B19 with a primary maternal infection during pregnancy. Pediatr Infect Dis J 17:489-494
21. Harger JH, Adler SP, Koch WC, Harger GF (1998) Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms. Obstet Gynecol 91:413-420
22. Gratacos E, Torres PJ, Vidal J, et al. (1995) The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infect Dis 171:1360-1363
23. Public Health Laboratory Service Working Party on Fifth Disease (1990) Prospective study of human parvovirus (B19) infection in pregnancy. BMJ 300:1166-1170
24. Miller E, Fairley CK, Cohen BJ, Seng C (1998) Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 105:174-178
25. Garceau L, Henderson J, Davis LJ, et al. (2002) Economic implications of assisted reproductive techniques: a systematic review. Hum Reprod 17:3090-3109
26. Gärtner BC, Fischinger JM, et al. (2007) Cost-effectiveness of hepatitis B vaccination in blood donors. (Manuskript in Vorbereitung)
27. Drummond MF, Sculpher MJ, Torrance GW, et al. (2005) Methods for the economic evaluation of health care programmes, 3rd edn. Oxford University Press, Oxford